SAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
September 20, 2024 16:18 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sage Therapeutics, Inc. (NASDAQ: SAGE) securities between April 12, 2021...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
September 20, 2024 12:49 ET
|
Glancy Prongay & Murray LLP
LOS ANGELES, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 28, 2024 deadline to file a lead plaintiff motion in the class...
World-Class Experts to Explore Innovations in NaaS and Automation at GNE 2024
September 19, 2024 13:52 ET
|
MEF
Leading industry executives will lead engaging sessions on the evolution of NaaS, ecosystem automation, and advanced technologies like AI and multi-cloud.
Levi & Korsinsky Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – SAGE
September 19, 2024 13:28 ET
|
Levi & Korsinsky, LLP
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Sage Therapeutics, Inc. ("Sage Therapeutics" or the "Company") (NASDAQ: SAGE) of a class action...
DEADLINE ALERT for OM, SAGE, and SMCI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
September 19, 2024 12:08 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics
September 19, 2024 10:09 ET
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Sage To Contact Him Directly To Discuss Their Options If you...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sage, Outset Medical, and Super Micro and Encourages Investors to Contact the Firm
September 18, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc. (SAGE) Shareholders
September 18, 2024 13:19 ET
|
The Gross Law Firm
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Sage Therapeutics, Inc. (NASDAQ: SAGE). Shareholders who purchased shares of SAGE...
Construction Software Market Poised to Reach US$ 4,133.1 Million by 2032 | Astute Analytica
September 18, 2024 09:30 ET
|
AstuteAnalytica India Pvt. Ltd.
New Delhi, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The global Construction software market was valued at US$ 2,016.6 million in 2023 and is projected to reach US$ 4,133.1 million by 2032 at a CAGR of...
SAGE CLASS ACTION: Sage Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Class Action Lawsuit
September 17, 2024 19:45 ET
|
Robbins LLP
Robbins LLP is Investigating Allegations that Sage Therapeutics, Inc. (SAGE) Misled Investors Regarding the Efficacy of its New Drugs